HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram
Contemporary Developments in MET-Selective Kinase Inhibitors in Advanced NSCLC
Trends in the development of MET inhibitors for hepatocellular carcinoma | Future Oncology
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
Recent advances in the discovery of small molecule c-Met Kinase inhibitors - ScienceDirect
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
MET Inhibition in Non-Small Cell Lung Cancer - European Medical Journal
Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors
c-Met inhibitor - Wikipedia
Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways - ScienceDirect
Biomedicines | Free Full-Text | Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment
cに応じられた阻害 | c-Met Inhibition
Frontiers | Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
c-Met inhibitor - Wikipedia
c-Met inhibitor 1 | c-Met/HGFR Inhibitor | MedChemExpress
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition | SpringerLink
Crizotinib is an Orally Active, ATP-Competitive ALK and c-Met inhibitor - Network of Cancer Research
c-Met inhibitor - Wikipedia
Classification of HGF/c-MET Inhibitors. | Download Table
![PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fb34e0b378ab283ee885fb912c61cc28ae8a288b/3-Figure1-1.png "PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar")
PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar
